Myosin molecules contains both heavy and light chains. There are two types of light chains present in one myosin molecule a regulatory light chain and an essential light chain.
| Inventor | Institute |
|---|---|
| Gurtej Dhoot | University of Birmingham |
| SKU: | 152432 |
|---|---|
| Product description: | Myosin molecules contains both heavy and light chains. There are two types of light chains present in one myosin molecule a regulatory light chain and an essential light chain. |
| Conjugation: | Unconjugated |
| Immunogen: | human skeletal muscle myosin |
| Cat. #: | 152432 |
|---|---|
| Unit size: | 100 ug |
| Research Fields: | Cell signaling and signal transduction;Tissue-specific biology |
| Application: | WB |
| Target: | Myosin light chains |
| Reactivity: | Human |
| Clone: | A12 |
| Host: | Mouse |
| Class: | Monoclonal |
| Target background: | Myosin molecules contains both heavy and light chains. There are two types of light chains present in one myosin molecule a regulatory light chain and an essential light chain. |
|---|
| Format: | Liquid |
|---|---|
| Concentration: | 0.9-1.1mg/ml |
| Storage buffer: | PBS with 0.02% azide |
| Storage conditions: | -20° C |
| Shipping conditions: | Dry ice |
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151026 | Anti-FCGR1 [10.1] mAb |
Key Info
Anti-FCGR1 [10.1] mAb
|
View Tool | |||||||||||||||||||
| 151016 | Anti-CyclinA [E72.1] |
Key Info
Anti-CyclinA [E72.1]
|
View Tool | |||||||||||||||||||
| 151022 | Anti-IL12 [1-1A4] |
Key Info
Anti-IL12 [1-1A4]
|
View Tool | |||||||||||||||||||
| 151027 | Anti-HSVICP8 [10A3] |
Key Info
Anti-HSVICP8 [10A3]
|
View Tool | |||||||||||||||||||
| 151034 | Anti-HSVUL42 [13D11] |
Key Info
Anti-HSVUL42 [13D11]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.